CRLCharles River Laboratories International, Inc.
Healthcare · Diagnostics & ResearchNYSEStockMkt cap $13.5B
Disclosed trades
10
0 in 30d · 0 in 90d
Politicians
6
Last trade May 15, 2025
Buys
5
$89K at range midpoints
Sells
5
$64.5K at range midpoints
Closing price · 365 days
Nov 6, 2025 – Nov 5, 2026
Monthly buys vs sells · 24 months
Counts of disclosed transactions
- Buys
- Sells (incl. partial)
Politicians who traded it
4 hold it now Estimated
| Politician | Seat | Trades | Buys | Sells | Bought (mid) | Sold (mid) | Last trade | Est. position Estimated |
|---|---|---|---|---|---|---|---|---|
| RJefferson Shreve | House · IN-06 | 2 | 1 | 1 | $32.5K | $32.5K | May 12, 2025 | $865 |
| DLois Frankel | House · FL-22 | 2 | 1 | 1 | $8K | $8K | Sep 8, 2023 | $811 |
| RRobert P. Bresnahan, Jr. | House · PA-08 | 2 | 1 | 1 | $32.5K | $8K | May 15, 2025 | $64.3K |
| DZoe Lofgren | House · CA-18 | 2 | 1 | 1 | $8K | $8K | Aug 25, 2022 | — |
| DDonna E. Shalala | House · FL-27 | 1 | 0 | 1 | $0 | $8K | Jun 24, 2019 | — |
| DJulie Johnson | House · TX-32 | 1 | 1 | 0 | $8K | $0 | Jan 15, 2025 | $14.4K |
Recent trades
| Politician | Ticker | Asset | Type | Owner | Amount | vs S&P Estimated | Traded | Filed | Source |
|---|---|---|---|---|---|---|---|---|---|
| RJefferson Shreve | CRL | Charles River Laboratories International, Inc. Common Stock (CRL) | Sell | Self | $15,001 - $50,000 | -90.3% | May 12, 2025 | Jun 22, 202541d | Filing |
| RJefferson Shreve | CRL | Charles River Laboratories International, Inc. Common Stock (CRL) | Buy | Self | $15,001 - $50,000 | +90.3% | May 8, 2025 | Jun 22, 202545d | Filing |
| RRobert P. Bresnahan, Jr. | CRL | Charles River Laboratories International, Inc. Common Stock (CRL) | Sell | Self | $1,001 - $15,000 | -108.1% | May 15, 2025 | May 31, 202516d | Filing |
| RRobert P. Bresnahan, Jr. | CRL | Charles River Laboratories International, Inc. Common Stock (CRL) | Buy | Self | $15,001 - $50,000 | +91.7% | Apr 8, 2025 | May 8, 202530d | Filing |
| DJulie Johnson | CRL | Charles River Laboratories International, Inc. Common Stock (CRL) | Buy | Joint | $1,001 - $15,000 | +81.8% | Jan 15, 2025 | Feb 12, 202528d | Filing |
| DLois Frankel | CRL | Charles River Laboratories International, Inc. (CRL) | Sell | Self | $1,001 - $15,000 | +8.7% | Sep 8, 2023 | Oct 10, 202332d | Filing |
| DLois Frankel | CRL | Charles River Laboratories International, Inc. (CRL) | Buy | Self | $1,001 - $15,000 | -17.3% | Apr 25, 2023 | May 19, 202324d | Filing |
| DZoe Lofgren | CRL | Charles River Laboratories International, Inc. (CRL) | Sell | Spouse | $1,001 - $15,000 | +39.8% | Aug 25, 2022 | Sep 13, 202219d | Filing |
| DZoe Lofgren | CRL | Charles River Laboratories International, Inc. (CRL) | Buy | Spouse | $1,001 - $15,000 | -92.0% | Sep 30, 2021 | Oct 7, 20217d | Filing |
| DDonna E. Shalala | CRL | Charles River Laboratories International, Inc. (CRL) | Sell | Self | $1,001 - $15,000 | — | Jun 24, 2019 | Apr 27, 2020308d | Filing |
Insider activity Filed
Insiders
24
Services-Commercial Physical & Biological Research
Open-market buys · 90d
1
$3K bought
Open-market sells · 90d
9
$31.1M sold
Net · 90d
-$31M
-$52.1M net over 12 months · last Oct 22, 2026
| Date | Insider | Kind | Security | Shares | Price | Value | Post-holdings | D/I | 10b5-1 | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2026filed Oct 26, 2026 | James C Foster | Exercise | Stock Options (Right to Buy)deriv. | −24,042 | $0.00 | — | 0 | D | 10b5-1 | 4 |
| Oct 22, 2026filed Oct 26, 2026 | James C Foster | Sale | Common Stock | −24,042 | $350.00 | $8,414,700 | 31,596 | D | 10b5-1 | 4 |
| Oct 22, 2026filed Oct 26, 2026 | James C Foster | Exercise | Common Stock | 24,042 | $244.41 | $5,876,105 | 55,638 | D | 10b5-1 | 4 |
| Oct 21, 2026filed Oct 23, 2026 | Shannon M ParisottoCEVP, Disc & Safety Assessment | Exercise | Stock Options (Right to Buy)deriv. | −2,156 | $0.00 | — | 719 | D | 10b5-1 | 4 |
| Oct 21, 2026filed Oct 23, 2026 | Shannon M ParisottoCEVP, Disc & Safety Assessment | Sale | Common Stock | −2,156 | $344.41 | $742,548 | 4,807 | D | 10b5-1 | 4 |
| Oct 21, 2026filed Oct 23, 2026 | Shannon M ParisottoCEVP, Disc & Safety Assessment | Exercise | Common Stock | 2,156 | $244.41 | $526,948 | 6,963 | D | 10b5-1 | 4 |
| Oct 5, 2026filed Oct 7, 2026 | Shannon M ParisottoCEVP, Disc & Safety Assessment | Exercise | Stock Options (Right to Buy)deriv. | −981 | $0.00 | — | 2,944 | D | 10b5-1 | 4 |
| Oct 5, 2026filed Oct 7, 2026 | Shannon M ParisottoCEVP, Disc & Safety Assessment | Sale | Common Stock | −981 | $308.44 | $302,580 | 4,807 | D | 10b5-1 | 4 |
| Oct 5, 2026filed Oct 7, 2026 | Shannon M ParisottoCEVP, Disc & Safety Assessment | Exercise | Common Stock | 981 | $208.44 | $204,480 | 5,788 | D | 10b5-1 | 4 |
| Sep 30, 2026filed Oct 2, 2026 | Glenn ColemanEVP & Chief Financial Officer | Buy | Common Stock | 10 | $297.43 | $2,974 | 27,762 | D | — | 4 |
Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4. Net figures count open-market buys minus open-market sales only (awards, exercises, withholding and gifts are excluded).
Unusual activity Estimated
- 51Exec buyPublic Feb 21, 2025 · traded Feb 20, 2025
CRL CEO Birgit Girshick bought $249K on the open market
Details
- Insider
- Birgit Girshick
- Company
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker
- CRL
- Tx kind
- open_market_buy
- Traded
- Feb 20, 2025
- Shares
- 1,514
- Price
- $165
- Value
- $249.2K
- Is 10b5 1
- No
- Filed
- Feb 21, 2025
- Public from
- Feb 21, 2025
- Method version
- 2026-11-03